213 related articles for article (PubMed ID: 21539673)
1. Tumor length assessed by miniprobe endosonography can predict the survival of the advanced esophageal squamous cell carcinoma with stricture receiving concurrent chemoradiation.
Chang WL; Lin FC; Yen CJ; Cheng H; Lai WW; Yang HB; Sheu BS
Dis Esophagus; 2011 Nov; 24(8):590-5. PubMed ID: 21539673
[TBL] [Abstract][Full Text] [Related]
2. Response evaluation with endoscopic ultrasound and computed tomography in esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
Chang WL; Wang WL; Chung TJ; Lin FC; Yen CJ; Lai WW; Yang HB; Sheu BS
J Gastroenterol Hepatol; 2015 Mar; 30(3):463-9. PubMed ID: 25088453
[TBL] [Abstract][Full Text] [Related]
3. High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy.
Cheng JC; Graber MS; Hsu FM; Tsai CL; Castaneda L; Lee JM; Chang DT; Koong AC
Ann Surg Oncol; 2014 Jul; 21(7):2361-8. PubMed ID: 24623035
[TBL] [Abstract][Full Text] [Related]
4. Does tumor size improve the accuracy of prognostic prediction in patients with esophageal squamous cell carcinoma after surgical resection?
Zhang H; Tang P; Miao X; Gao Y; Shang X; Gong L; Ma Z; Yang M; Jiang H; Zhan Z; Meng B; Yu Z
Oncotarget; 2016 Oct; 7(41):66623-66634. PubMed ID: 27579613
[TBL] [Abstract][Full Text] [Related]
5. Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
Lin WC; Ding YF; Hsu HL; Chang JH; Yuan KS; Wu ATH; Chow JM; Chang CL; Chen SU; Wu SY
Cancer; 2017 Oct; 123(20):3904-3915. PubMed ID: 28608916
[TBL] [Abstract][Full Text] [Related]
6. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
[TBL] [Abstract][Full Text] [Related]
7. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of serial endoscopic ultrasound after chemoradiation in esophageal cancer.
Bohle W; Kasper M; Zoller WG
Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859390
[TBL] [Abstract][Full Text] [Related]
9. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
[TBL] [Abstract][Full Text] [Related]
10. Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae.
Ma L; Luo GY; Ren YF; Qiu B; Yang H; Xie CX; Liu SR; Liu SL; Chen ZL; Li Q; Fu JH; Liu MZ; Hu YH; Ye WF; Liu H
Chin J Cancer; 2017 Jan; 36(1):8. PubMed ID: 28077159
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the endoscopic ultrasound defined lymph node metastasis count in esophageal cancer.
Twine CP; Roberts SA; Rawlinson CE; Davies L; Escofet X; Dave BV; Crosby TD; Lewis WG
Dis Esophagus; 2010 Nov; 23(8):652-9. PubMed ID: 20545976
[TBL] [Abstract][Full Text] [Related]
12. Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02).
Jost C; Binek J; Schuller JC; Bauerfeind P; Metzger U; Werth B; Knuchel J; Frossard JL; Bertschinger P; Brauchli P; Meyenberger C; Ruhstaller T
Gastrointest Endosc; 2010 Jun; 71(7):1114-21. PubMed ID: 20304399
[TBL] [Abstract][Full Text] [Related]
13. Treatment of clinical T2N0M0 esophageal cancer.
Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic ultrasonography is useful for monitoring the tumor response of neoadjuvant chemoradiation therapy in esophageal squamous cell carcinoma.
Owaki T; Matsumoto M; Okumura H; Uchicado Y; Kita Y; Setoyama T; Sasaki K; Sakurai T; Omoto I; Shimada M; Sakamoto F; Yoshinaka H; Ishigami S; Ueno S; Natsugoe S
Am J Surg; 2012 Feb; 203(2):191-7. PubMed ID: 21679919
[TBL] [Abstract][Full Text] [Related]
15. Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
Zhou XL; Zhu WG; Zhu ZJ; Wang WW; Deng X; Tao WJ; Ji FZ; Tong YS
Oncologist; 2019 Aug; 24(8):e677-e686. PubMed ID: 31040254
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of endoscopic ultrasonography non-traversability in patients with locoregional esophageal cancer receiving multimodality therapy.
Cho CJ; Song HJ; Lee GH; Choi KD; Kim YH; Ryu JS; Kim SB; Kim JH; Park SI; Jung HY
Korean J Intern Med; 2017 May; 32(3):443-451. PubMed ID: 26972059
[TBL] [Abstract][Full Text] [Related]
17. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
[TBL] [Abstract][Full Text] [Related]
18. Impact of endoscopic ultrasound combined with fine-needle aspiration biopsy in the management of esophageal cancer.
Chang KJ; Soetikno RM; Bastas D; Tu C; Nguyen PT
Endoscopy; 2003 Nov; 35(11):962-6. PubMed ID: 14606021
[TBL] [Abstract][Full Text] [Related]
19. Prediction of survival by tumor area on endosonography after definitive chemoradiotherapy for locally advanced squamous cell carcinoma of the esophagus.
Shim CN; Song MK; Lee HS; Chung H; Lee H; Shin SK; Lee SK; Lee YC; Park JC
Digestion; 2014; 90(2):98-107. PubMed ID: 25196528
[TBL] [Abstract][Full Text] [Related]
20. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
